83 related articles for article (PubMed ID: 17311836)
1. Schizophrenia: multi-attribute utility theory approach to selection of atypical antipsychotics.
Bettinger TL; Shuler G; Jones DR; Wilson JP
Ann Pharmacother; 2007 Feb; 41(2):201-7. PubMed ID: 17311836
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia.
Obradovic M; Mrhar A; Kos M
Int J Clin Pract; 2007 Dec; 61(12):1979-88. PubMed ID: 17997804
[TBL] [Abstract][Full Text] [Related]
3. A multiattribute decision model for bipolar disorder: identification of preferred mood-stabilizing medications.
Suehs BT; Bettinger TL
Am J Manag Care; 2009 Jul; 15(7):e42-52. PubMed ID: 19589006
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
5. Sexual dysfunction in schizophrenia: focus on recent evidence.
Baggaley M
Hum Psychopharmacol; 2008 Apr; 23(3):201-9. PubMed ID: 18338766
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
Vohora D
Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
[TBL] [Abstract][Full Text] [Related]
7. Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?
Motlová L; Spaniel F; Höschl C; Balon R
Ann Clin Psychiatry; 2007; 19(2):133-43. PubMed ID: 17612853
[TBL] [Abstract][Full Text] [Related]
8. Impact of atypical antipsychotics on outcomes of care in schizophrenia.
Joyce AT; Harrison DJ; Loebel AD; Ollendorf DA
Am J Manag Care; 2005 Sep; 11(8 Suppl):S254-61. PubMed ID: 16180964
[TBL] [Abstract][Full Text] [Related]
9. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.
Nasrallah HA
J Clin Psychiatry; 2007; 68 Suppl 1():5-11. PubMed ID: 17286522
[TBL] [Abstract][Full Text] [Related]
10. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
[TBL] [Abstract][Full Text] [Related]
11. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.
Gau SS; Chung CH; Gau CS
J Clin Psychopharmacol; 2008 Jun; 28(3):271-8. PubMed ID: 18480683
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine: a new atypical antipsychotic for the treatment of schizophrenia.
Gray R
Ment Health Care; 1998 Jan; 1(5):163-4. PubMed ID: 9791402
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
[TBL] [Abstract][Full Text] [Related]
14. Multiattribute evaluation in formulary decision making as applied to calcium-channel blockers.
Schumacher GE
Am J Hosp Pharm; 1991 Feb; 48(2):301-8. PubMed ID: 2003506
[TBL] [Abstract][Full Text] [Related]
15. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
Keith S
Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic agents in the treatment of bipolar mania.
Tohen M; Vieta E
Bipolar Disord; 2009 Jun; 11 Suppl 2():45-54. PubMed ID: 19538685
[TBL] [Abstract][Full Text] [Related]
17. Use of atypical antipsychotics in the treatment of autistic disorder.
Stachnik JM; Nunn-Thompson C
Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
[TBL] [Abstract][Full Text] [Related]
18. Comparing efficacy of first-line atypical antipsychotics: no evidence of differential efficacy between risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole.
Tandon R; Jibson MD
Int J Psychiatry Clin Pract; 2005; 9(3):204-12. PubMed ID: 24937792
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatment strategies for schizophrenia.
Lindenmayer JP; Khan A
Expert Rev Neurother; 2004 Jul; 4(4):705-23. PubMed ID: 15853589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
